ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy)

Arrhythmogenic Right Ventricular Dysplasia (ARVD) is a heart condition. It affects the right side of the heart, causing it to beat irregularly. This can lead to serious problems like fainting or sudden death.

ConditionRare Disease

What people with ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) report

Every report comes from a Lived member, sent anonymously.

Have you had Implantable Cardioverter Defibrillators for ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy)?

NameHow it went

About ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy)

What It Is

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease of the heart muscle. Over time, healthy muscle is replaced by scar tissue and fat, most often in the right ventricle, the chamber that pumps blood to the lungs. That patchy tissue disrupts the heart's electrical signals and can set off ventricular arrhythmias: fast, abnormal rhythms that start in the heart's lower chambers. These rhythms are the main danger of ARVC, and they can cause fainting or sudden cardiac arrest. ARVC is rare, affecting roughly 1 in 2,000 to 1 in 5,000 people, and is usually recognized in adults between about 20 and 40, though it can appear in the teenage years. Early on, many people have no symptoms at all. When symptoms appear, they often include palpitations (a pounding or fluttering heartbeat), lightheadedness or fainting, sometimes brought on by exercise. In some people, sudden cardiac arrest is the first sign, which is why ARVC is an important cause of sudden death in young people and athletes. The older name, arrhythmogenic right ventricular dysplasia (ARVD), is still common. Doctors increasingly use the broader term arrhythmogenic cardiomyopathy, because some forms also or mainly affect the left ventricle.

Causes & Risk Factors

Most ARVC is genetic. The genes involved usually help build desmosomes, the structures that hold heart muscle cells together. When they do not work properly, cells can pull apart and die, especially when the heart is under strain, and scar and fat fill in the gaps. A gene change is found in about half to 60 percent of people with ARVC, most often in a gene called PKP2. In the rest, no genetic cause can be identified yet. ARVC is usually inherited in an autosomal dominant pattern, meaning a parent with the gene change has a 50 percent chance of passing it to each child. Inheriting it does not mean someone will develop the disease: many carriers have mild signs or none, and the age of onset and severity can differ widely, even within one family. Rare recessive forms, such as Naxos disease, also cause woolly hair and thickened skin on the palms and soles. Vigorous exercise is the best-studied factor that changes the course. In people with ARVC and in gene carriers, frequent high-intensity endurance exercise is linked to earlier onset, more arrhythmias and worse heart function. Exercise seems mainly to act on an inherited tendency, but in some people with no gene change found, very intense, long-term endurance training may play a larger role. The link appears weaker in some left-sided genetic forms.

How It's Diagnosed

No single test confirms ARVC. Cardiologists use a set of diagnostic criteria (the Task Force Criteria) that combine findings from several sources and grade the result as definite, borderline or possible ARVC. These include the structure and pumping of the right ventricle on an echocardiogram (heart ultrasound) or cardiac MRI; characteristic electrocardiogram (ECG) patterns, such as a characteristic change in the heart's recovery phase on the tracings over the right side of the heart; the type and number of extra or abnormal beats recorded on a 24-hour Holter monitor; family history; and genetic test results. A heart tissue biopsy is used only occasionally. Cardiac MRI is especially useful because it can show both how the ventricles move and where scar is present. Genetic testing helps confirm the diagnosis, can point to a gene-specific risk profile and lets relatives be tested for the same change. Several other conditions can look like ARVC, including myocarditis (inflammation of the heart muscle), cardiac sarcoidosis and the enlarged but healthy heart some endurance athletes develop. Diagnosis is often best made or confirmed at a center experienced with inherited heart disease. Because ARVC runs in families, guidelines recommend that parents, siblings and children of someone with ARVC be checked with an ECG, Holter monitor and heart imaging, starting around age 10 to 12 and repeated every 1 to 3 years. When a gene change is known, relatives can be tested for it; those who do not carry it usually do not need ongoing heart screening.

Treatment Options

There is no treatment yet that reverses ARVC. Care aims to prevent sudden death, control arrhythmias and symptoms, and slow damage to the heart. Limiting exercise is a central part of treatment. People with ARVC, and gene carriers without signs of disease, are advised to avoid competitive sports and frequent high-intensity endurance exercise. Cutting back after diagnosis is associated with fewer dangerous arrhythmias. Lighter activity is usually still possible, and a cardiologist can help decide what level of activity is reasonable. Giving up competitive or endurance sport can be a significant loss for people whose lives centered on it. Beta-blockers, medicines that blunt the effect of adrenaline on the heart, are the usual first medication. When arrhythmias continue, an antiarrhythmic medicine such as flecainide or sotalol may be added; amiodarone is generally reserved for later because of its long-term side effects. No medicine has been tested in clinical trials specifically for ARVC, so these choices rest on experience at specialist centers. An implantable cardioverter-defibrillator (ICD) is a small device placed under the skin that watches the heart rhythm and delivers a shock to stop a life-threatening arrhythmia. It is the only treatment proven to prevent sudden death. It is clearly recommended after a cardiac arrest or sustained ventricular tachycardia (a fast rhythm from the lower chambers that keeps going rather than stopping on its own). For others, the decision weighs individual risk, using factors such as age, sex, fainting, the number of abnormal beats and right ventricle function, sometimes with an online risk calculator. Because ICDs can cause complications, unnecessary shocks and emotional strain, they are not placed in everyone. Catheter ablation, which uses heat to destroy the small areas of scar that trigger arrhythmias, can reduce episodes and shocks when medicines are not enough. It often requires reaching the outer surface of the heart, may need to be repeated, and does not replace an ICD for someone at high risk. If heart failure develops, it is treated with standard heart failure medicines, and a heart transplant is occasionally needed.

What to Expect

ARVC is lifelong, and its course varies a great deal. Some people have few symptoms for years, while others have arrhythmias early or develop weakening of one or both ventricles. Structural changes usually progress slowly, and electrical changes on an ECG or Holter monitor often show up before changes on imaging. Over a lifetime, up to half of people develop symptoms of heart failure, such as breathlessness or swelling. With earlier diagnosis, exercise changes and ICDs where needed, the long-term outlook for many people is good. Daily life usually involves taking medicines, regular cardiology visits with ECGs, monitors and imaging, and device checks for anyone with an ICD. Adjusting to exercise limits and to living with a device can be hard, and some people find support from a counselor or patient group helpful. Genetic counseling helps families understand what a result means for relatives and for future children. Because many relatives will need screening over many years, family members often become part of the care plan too. Household members may wish to learn cardiopulmonary resuscitation (CPR).

When to Seek Help

See a doctor for an evaluation if you have unexplained palpitations or fainting, or if a close relative has ARVC or died suddenly and unexpectedly at a young age. If you have ARVC, let your care team know if you develop new or worsening shortness of breath, swelling in your legs or belly, or unusual tiredness, which can signal heart failure. Contact your cardiology team promptly if palpitations are becoming more frequent or longer, or if you had a brief episode of a racing heartbeat or near-fainting that has fully passed. Call 911 if a racing or pounding heartbeat is happening now with dizziness, near-fainting, chest pain or shortness of breath, or if you faint during or just after exertion. These can be signs of a dangerous arrhythmia. If you have an ICD, follow the plan your device team gives you for what to do after a shock. If someone collapses and is unresponsive or not breathing normally, call 911, start CPR and use an automated external defibrillator (AED) if one is available.

Questions to Ask Your Doctor

  1. 1.Which tests support my diagnosis, and could another condition, such as myocarditis or sarcoidosis, explain these findings?
  2. 2.What is my estimated risk of a dangerous arrhythmia, and do I need an ICD now or later?
  3. 3.What kinds and levels of physical activity are reasonable for me?
  4. 4.Should I have genetic testing, and which relatives should be screened or tested, and how often?
  5. 5.How often should I have follow-up tests, and what changes would prompt a change in my treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.